ahlam1399
09-09-2015, 03:33 AM
Pacira sues FDA over pain drug marketing restrictions
NEW YORK (Reuters) - Pacira Pharmaceuticals Inc on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel, for a wide range of surgeries, which the U.S. Food and Drug Administration opposes.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49adc3ad/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=-NP73OnXVEY:aNsCDThYlEA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-NP73OnXVEY:aNsCDThYlEA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=-NP73OnXVEY:aNsCDThYlEA:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-NP73OnXVEY:aNsCDThYlEA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=-NP73OnXVEY:aNsCDThYlEA:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/-NP73OnXVEY
NEW YORK (Reuters) - Pacira Pharmaceuticals Inc on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel, for a wide range of surgeries, which the U.S. Food and Drug Administration opposes.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49adc3ad/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=-NP73OnXVEY:aNsCDThYlEA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-NP73OnXVEY:aNsCDThYlEA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=-NP73OnXVEY:aNsCDThYlEA:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-NP73OnXVEY:aNsCDThYlEA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=-NP73OnXVEY:aNsCDThYlEA:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/-NP73OnXVEY